BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35931978)

  • 41. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
    Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
    Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M; Vocaturo A; Caraceni D; French D; Rosini S; Zappacosta R; Terrenato I; Ciccocioppo L; Frega A; Giorgi Rossi P
    J Clin Microbiol; 2011 Jul; 49(7):2643-50. PubMed ID: 21525231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.
    Li B; Guo R; Lai T; Qiao L; Fu H
    J Obstet Gynaecol Res; 2021 Aug; 47(8):2720-2728. PubMed ID: 34036681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type.
    Nakagawa S; Yoshikawa H; Yasugi T; Kimura M; Kawana K; Matsumoto K; Yamada M; Onda T; Taketani Y
    J Med Virol; 2000 Oct; 62(2):251-8. PubMed ID: 11002256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN).
    Galarowicz B; Jach R; Kidzierska J; Dyduch G; Zajac K; Pityński K; Banaś T; Huras H; Streb J; Dulińska-Litewka J; Hosiawa V; Juszczak M; Milewicz T
    Przegl Lek; 2012; 69(9):651-7. PubMed ID: 23401983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
    BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
    Shen Y; Gong J; He Y; Cheng G; Okunieff P; Li X
    J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
    Antonishyn NA; Horsman GB; Kelln RA; Severini A
    Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L; Zhu Y; Bai Y; Zhang X; Ren C
    J Cancer Res Ther; 2017; 13(4):613-620. PubMed ID: 28901302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
    J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
    Abedin S; Paul SK; Haque N; Ahmed S; Nasreen SA; Akhter N; Haque N; Sarkar SR; Roy S; Nahar F; Ahmed MU; Switzer J; Kobayashi N; Hossain MA; Chowdhury UW
    Mymensingh Med J; 2019 Jan; 28(1):31-36. PubMed ID: 30755547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
    Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
    Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.
    Hovland S; Muller S; Skomedal H; Mints M; Bergström J; Wallin KL; Karlsen F; Johansson B; Andersson S
    Int J Oncol; 2010 Jun; 36(6):1533-9. PubMed ID: 20428778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey.
    Tüney İ; Altay A; Ergünay K; Önder SÇ; Usubütün A; Salman MC; Bozdayi G; Karabulut E; Badur OS; Yüce K; Pinar A
    Turk J Med Sci; 2017 Feb; 47(1):194-200. PubMed ID: 28263489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
    Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
    Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing.
    Kottaridi C; Tsiodras S; Spathis A; Chranioti A; Pappas A; Kassanos D; Panayiotides I; Karakitsos P
    Anal Quant Cytol Histol; 2011 Dec; 33(6):305-10. PubMed ID: 22590807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.